Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News PTC Therapeutics completes $200m acquisition of Agilis Biotherapeutics to expand gene therapy portfolio In a major strategic move, US biopharmaceutical company PTC Therapeutics has finalized its acquisition of Agilis Biotherapeutics, a… bypharmanewsdailyAugust 25, 2018
